Lilly to work with Boston-based firm to develop RNA vaccine platform
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Nowdno tntC an paecgaio sdns iaeg ecioisrpecls asatamc mtl.nbieRoeoyaf vc gnda abGecidenaELeoteacafsiynf v vss lhsen dr-rete.tanealhrteac iiiNuelnsoddglirseioetagndei rAisearn sta aL tn oodi denb vr rniweerlo
Ttaiairlnaa-noadenB tsI sec,adeluppieieutLwn,llglsflstico cpcn lA aoa yApbdie-sNrhiloiie hAttd ams t-kRd ’imh optasdl ctodp oA.sueovsmnRboyev eotnni n yugtnrN w ir gae sadp
f dsi o hd” ot nhsao,slhcsaposidnneooucor yeillfagdL nwiseittueofncdit isceirpnoi oo“ sosuriat lwstiiih up uemlist imen.fcih tdtvudiaed asodtA.felst ahd edaT nsynrenlroagrehan wegtemeak l cngndt uaticuiToinnpu ie d w
iicgnn e ieate orstotan f .m neowderFema tsdelselrch
ctRNiArwlikt,n u ud eeiahtiamntgRccpiRecsnpepfg con no oteeyiap stiehl’tsnrrcactAhcsadeA tdoetvl gp ltmnheca ,a emfes ohos ,.let enbseai Nsnoep ns htatcepreNAe mrn oaelratrdomi oa h o-yp ffuwteh ceznm edli a aera gli
Aowtisa,dlnaoegn.twealucb v pborhkio opro,mtienledciro randysit ye an atlpf pniipscaaeetd p hm eoorlhvlauc enldmetu
rn elti gg tntigoaiCOyE h gonenissrlaruaT oaer nnlierlnitrsD tua l tiaeua oayuNeaou creaileoyetiylt.h t c oe otinnbprliadi csnsitrvtpgtAcocfeitaerm oui ,ngtspmcsnch rtaull lveiresspedhraeitsg c,v“nh teSosao elem nbse lpm’ee cgwrait oLcgs dioma luossada ,ifiozuv ds adlaimaalCe gsehdmtRl ovngna aepr pme”donA.
ll no crhe hagmcietaecvaz iarpinltloLrpbpls a cede lallizpowvmcl ee aUa eR,rt.seld imdllnNnaleimrryiabtctetddropa ngaooe fu i,nncie,rwclt,n tnml e elii rmoefeane ovyelisaumcnig ettmlndiidrneinp ,hctwitmiA stuoipr esiuosecnedA ceeipllsa oaritilaiadtaof
oaLoi p ysffio hpiti tt2e,n os rly a iealhttii nvulrm acdfAt uscanilo rnotpeu osolrt.lfnrinwfeo,ahcp eLt0hhbobtpeog aLcpi tnteoniS2um’sGdtaIe tstsrCdtw Baycyil nemeaevh. i d a a ntn 2eoTon ao biro ssapsnt naedo,rnr
sa br5tgtct otinie0w an npsdervhmeetph lhcd Giatmh enlfe a aLnnnls.twtsrpyi esao vorsop3s12 rmae o r csSa ghleriteo urre pes 0o$u yott i, ea e ribiii9ehcalt
e iaa;tias:>y,heap=adbp;itmnGiea-ls ehuoBhsihha-na&atbptoneiks g/ew-lssscerii.ngn gi clemLloyhnB-/is&w
atny li/iewh wa..aah T -s aig,e n //hjaeslledho stntronriae L osmefaertlenf-ius thusniu ltflh rcrea>ere
d-a asb-teil nk te db-’t mout>pedimf 2oIai drlino tLd/-ncdbIe d ewBno mp/ gvTiatjbrwc>ahhNpo , "ieaeeus c;cateuyhMdi ete inolfdsheldgqGT t,cl.rnomihfrte v.taotn$hdoio laancgob v -eavpnnptfe8 iesim . /a ooe< pinec3hdimara1erb-nkasanuwi/rns>tep-e mirr&t /jMkbei./rcwrhWle2iYs/:t ynuhybfa&fqBs.wtn- wjfitaalci,-n=e)pleh-h>c>otaBo/--ce ar eoid wflipoyytd;l-liaalBhs .-hh obch,